CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-07 | Furlow Brenda S. SVP - GENERAL COUNSEL | Option exercise · Stock Options (Right to Buy) | −800 | 37,212 | ||
| 2022-10-27 | HIGGINS JOHN L Director | Grant or award | +338 | 5,840 | ||
| 2022-10-27 | HIGGINS JOHN L Director | Grant or award · Stock Options (Right to Buy) | +865 | 865 | ||
| 2022-10-27 | BAUMGARTNER ROBERT V Director | Grant or award | +338 | 10,444 | ||
| 2022-10-27 | BAUMGARTNER ROBERT V Director | Grant or award · Stock Options (Right to Buy) | +865 | 865 | ||
| 2022-10-27 | VESSEY RUPERT Director | Grant or award | +338 | 1,565 | ||
| 2022-10-27 | VESSEY RUPERT Director | Grant or award · Stock Options (Right to Buy) | +865 | 865 | ||
| 2022-10-27 | Nusse Roeland Director | Grant or award | +338 | 7,297 | ||
| 2022-10-27 | Nusse Roeland Director | Grant or award · Stock Options (Right to Buy) | +865 | 865 | ||
| 2022-10-27 | KEEGAN JOSEPH D Director | Grant or award | +338 | 2,671 | ||
| 2022-10-27 | KEEGAN JOSEPH D Director | Grant or award · Stock Options (Right to Buy) | +865 | 865 | ||
| 2022-10-27 | Bushman Julie L Director | Grant or award | +338 | 1,012 | ||
| 2022-10-27 | Bushman Julie L Director | Grant or award · Stock Options (Right to Buy) | +865 | 865 | ||
| 2022-10-27 | Seth Alpna Director | Grant or award | +338 | 2,671 | ||
| 2022-10-27 | Seth Alpna Director | Grant or award · Stock Options (Right to Buy) | +865 | 865 | ||
| 2022-10-27 | STEER RANDOLPH C Director | Grant or award | +338 | 5,644 | ||
| 2022-10-27 | STEER RANDOLPH C Director | Grant or award · Stock Options (Right to Buy) | +865 | 865 | ||
| 2022-08-23 | Kelderman Kim Pres. Diagnostics & Genom | Option exercise | +663 | $150.78 | $100K | 3,801 |
| 2022-08-23 | Kelderman Kim Pres. Diagnostics & Genom | Option exercise · Stock Option (Right to Buy) | −663 | 6,848 | ||
| 2022-08-15 | Kummeth Charles R. Chief Executive Officer | Grant or award · Restricted Stock Units | +13,225 | 13,225 |
Page 22 of 32 · 626 trades